Advent Technologies (ADN) investor relations material

Executive summary

• Focused on hydrogen fuel cell and MEA technology, with operations in the US and Greece after exiting Denmark and the Philippines due to bankruptcy of Advent Technologies A/S in July 2024.

• Revenue primarily from fuel cell systems, MEAs, and related services, with ongoing grant funding and R&D partnerships.

• Significant business developments include a €34.5M EU Innovation Fund grant for the RHyno Project and ongoing collaborations with Airbus and the US Department of Defense.

Financial highlights

• Revenue for Q3 2025 was $62K, down 52% year-over-year; nine-month revenue was $293K, down 92% year-over-year.

• Net income from continuing operations for Q3 2025 was $8.6M, compared to a $9.6M loss in Q3 2024; nine-month net income was $1.6M, compared to a $29.2M loss year-over-year.

• Net loss from discontinued operations was $8.9M for Q3 2025 and $9.9M for the nine months ended September 30, 2025.

• Cash and cash equivalents at September 30, 2025, were $0.5M, with a working capital deficit of $16.0M.

• EBITDA for Q3 2025 was $(2.2)M, improved from $(7.8)M in Q3 2024.

Outlook and guidance

• Management expresses substantial doubt about the ability to continue as a going concern due to recurring losses, negative working capital, and insufficient cash to fund operations for the next twelve months.

• Plans to raise additional capital through equity or debt and reduce expenditures; delays or failure to secure funding could result in curtailment or termination of operations.